Skip to content

Analysis of Brain Structure and White Matter Integrity in Type 2 Diabetes Mellitus with Preclinical Cognitive Impairment

Analysis of Brain Structure and White Matter Integrity in Type 2 Diabetes Mellitus with Preclinical Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035580
Enrollment
Unknown
Registered
2020-08-14
Start date
2021-02-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: T2DM: 1. patients with T2DM who meet the diagnostic and treatment criteria of the American Diabetes Association ((American Diabetes Association,ADA) in 2019; 2. aged > = 50 years old; 3. right-handed, can cooperate with MRI examination; 4. voluntarily participate in the investigation and sign the informed consent form. Normal control group: 1. no history of diabetes; 2. aged > = 50 years; 3. right-handed, which can cooperate with MRI examination; 4. voluntarily participated in the investigation and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes, pre-diabetes, acute metabolic complications of diabetes; 2. Have a family history of dementia and are taking drugs to improve cognition (such as cholinesterase inhibitors, NMDA receptor antagonists and ginkgo biloba preparations, etc.); 3. Cannot tolerate and cooperate with MRI examination; 4. Consciousness disorder caused by hypoglycemia occurred in the past 3 years; 5. Severe mental illness, drug addiction, head injury and stroke, or other diseases that affect cognitive function; 6. Severe visual or hearing impairment; 7. Major medical diseases (such as cancer, anemia, thyroid dysfunction, etc.).

Design outcomes

Primary

MeasureTime frame
HbA1c;insulin and C-peptide;FPG;fractional anisotropy;mean diffusivity;Gray Matter Volume;Magnetic resonance image;

Secondary

MeasureTime frame
Baseline information, such as height, weight and blood pressure;blood routine;liver function;renal function;

Countries

China

Contacts

Public ContactYA MIAO

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

nning-my@163.com+86 021 24058545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026